IP21-13: Urinary outcomes of International Prostate Symptom Score phenotypes following transurethral resection of the prostate: a secondary analysis of the Prostate Cancer Prevention Trial

IP21-13: Urinary outcomes of International Prostate Symptom Score phenotypes following transurethral resection of the prostate: a secondary analysis of the Prostate Cancer Prevention Trial

Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)

146B

Abstract

Speakers

Connor Chestnut

Connor Chestnut

ResidentUniversity of Washington

Sessions

IP21: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology III

Friday, May 15, 2026 3:30 PM to 5:30 PM

Michael Borofsky · University of Minnesota Medical Center

James Forde · Beaumont Hospital

Nicole Miller · Vanderbilt Univ Med Ctr

Log in

See all the content and easy-to-use features by logging in or registering!